Lattice Corneal Dystrophy Type 2 Latest Advances

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: May 25, 2019

Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.

Journal: The international journal of cardiovascular imaging

Published: November 30, 2018

Deep Learning Algorithms for Corneal Amyloid Deposition Quantitation in Familial Amyloidosis.

Journal: Ocular oncology and pathology

Published: October 30, 2018

Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: October 16, 2018

Selective and Sensitive Pull Down of Amyloid Fibrils Produced in Vitro and in Vivo by the Use of Pentameric-Thiophene-Coupled Resins.

Journal: ACS chemical neuroscience

Published: May 16, 2018

Lattice Corneal Dystrophy Type 2 Latest Advances

Find the Latest Research About Lattice Corneal Dystrophy Type 2

Clinical and genetical diagnosis of a case of Meretoja syndrome and frontotemporal lifting procedure.

Clinical and genetical diagnosis of a case of Meretoja syndrome and frontotemporal lifting procedure.

A novel GSN variant outside the G2 calcium-binding domain associated with Amyloidosis of the Finnish type.

A novel GSN variant outside the G2 calcium-binding domain associated with Amyloidosis of the Finnish type.

Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel GSN Variant p.Glu580Lys.

Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel GSN Variant p.Glu580Lys.

Severe ocular involvement in hereditary gelsolin amyloidosis.

Severe ocular involvement in hereditary gelsolin amyloidosis.

Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.

Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.

Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.

Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.

The role of gelsolin domain 3 in familial amyloidosis (Finnish type).

The role of gelsolin domain 3 in familial amyloidosis (Finnish type).

Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.

Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.

Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.

Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.

Deep Learning Algorithms for Corneal Amyloid Deposition Quantitation in Familial Amyloidosis.

Deep Learning Algorithms for Corneal Amyloid Deposition Quantitation in Familial Amyloidosis.

Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant.

Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant.

Selective and Sensitive Pull Down of Amyloid Fibrils Produced in Vitro and in Vivo by the Use of Pentameric-Thiophene-Coupled Resins.

Selective and Sensitive Pull Down of Amyloid Fibrils Produced in Vitro and in Vivo by the Use of Pentameric-Thiophene-Coupled Resins.